SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-107593
Filing Date
2018-04-04
Accepted
2018-04-04 16:49:56
Documents
2
Period of Report
2018-03-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d564113d8k.htm 8-K 18217
2 EX-3.2 d564113dex32.htm EX-3.2 104038
  Complete submission text file 0001193125-18-107593.txt   123694
Mailing Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36829 | Film No.: 18737854
SIC: 2834 Pharmaceutical Preparations